13 completed, 10 recruiting, 10 unknown, 3 terminated. 18 Phase 4, 7 Not applicable, 4 Phase 2, 3 Phase 3, 2 Phase 1.
Follow Beta blocker: new trials by email Literature Review of Beta blocker trials Research Report on Beta blocker
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| UPBEAT: Using Polygenic Scores to Guide BB Therapy in HF With Mildly Reduced EF Beta blocker - Heart Failure, Polygenic Score | Not applicable | Recruiting | David Lanfear | 10 | 2026-03-30 | 2026-07-07 |
| Study of Corneal Biomechanics in Glaucoma Patients Using Brillouin Microscopy Prostaglandin Analogue -Containing IOP-Lowering Therapy, Beta Blocker, Brillouin Microscopy - Glaucoma | Recruiting | University of Maryland, Baltimore | 60 | 2025-09-01 | 2026-08-10 | |
| Short-Term Effects of Antihypertensive Drugs on Postural Balance and Fall Risk Beta Blocker, ACE inhibitor, Calcium channel blocker - Hypertension, Fall Risk | Not applicable | Recruiting | Abant Izzet Baysal University | 186 | 2025-08-01 | 2026-02-12 |
| Beta-Blockers in Takotsubo Syndrome Study Beta blocker - Takotsubo Cardiomyopathy, Beta-blockers | Phase 4 | Not yet recruiting | Spanish Society of Cardiology | 200 | 2024-08-01 | 2024-08-26 |
| Impact of Beta Blockers on TAVI (BETA-TAVI) Beta blocker - Aortic Valve Stenosis | Phase 4 | Recruiting | National and Kapodistrian University of Athens | 348 | 2024-06-01 | 2026-11-09 |
| Detoxification From the Lipid Tract electroencephalogram biofeedback, electrical brain stimulation, ultra-low frequency transcranial magnetic stimulation - COVID-19 Vaccine Adverse Reaction | Phase 4 | Completed | Pachankis, Yang I., M.D. | 1 | 2024-02-26 | 2024-04-10 |
| A Preliminary Study for INFORMED Beta blocker - Heart Failure, Heart Failure, Diastolic | Phase 4 | Recruiting | Weill Medical College of Cornell University | 18 | 2024-02-07 | 2026-08-21 |
| N-of-1 for Beta-Blockers in Cardiac Amyloidosis Beta blocker - Cardiac Amyloidosis, Heart Diseases | Phase 4 | Completed | Weill Medical College of Cornell University | 14 | 2024-01-31 | 2026-07-29 |
| LIVEBETTER: A Trial Comparing Medications in Older Adults With Stable Angina and Multiple Chronic Conditions Clinician Discretion, Beta blocker, Calcium channel blocker - Angina, Stable Ischemic Heart Disease | Phase 4 | Recruiting | Yale University | 741 | 2023-05-10 | 2026-04-07 |
| Role of Ivabradine on Heart Rate and Quality of Life in Patients With Mitral Stenosis in Sinus Rhythm Ivabradine, Beta blocker - Mitral Stenosis | Phase 4 | Completed | Bangabandhu Sheikh Mujib Medical University, Dhaka, Bangladesh | 42 | 2023-02-01 | 2024-04-17 |
| Long-term Use of CCB and Breast Cancer Risk Calcium channel blocker, Beta blocker, Diuretic - Hypertension,Essential, Breast Cancer | Unknown | Curtin University | 68500 | 2022-07-01 | 2024-08-21 | |
| Non-chemotherapeutic Interventions for the Improvement of Quality of Life and Immune Function in Patients With Multiple Myeloma Behavioral Intervention, Beta-Adrenergic Antagonist, Propranolol - Plasma Cell Myeloma, Recurrent Plasma Cell Myeloma | Not applicable | Recruiting | Roswell Park Cancer Institute | 265 | 2022-06-28 | 2026-11-09 |
| Randomized Trial to Examine a Differential Therapeutic Response in Symptomatic Patients With Non-obstructive Coronary Artery Disease Bisoprolol, Diltiazem, Placebo - Coronary Microvascular Dysfunction, Microvascular Angina | Phase 4 | Unknown | Charite University, Berlin, Germany | 132 | 2022-03-04 | 2022-03-24 |
| Prognostic Value of Precision Medicine in Patients With MINOCA (PROMISE Trial). Coronary angiography, OCT imaging, Percutaneous coronary intervention (PCI): - Myocardial Infarction With Non-Obstructive Coronary Arteries | Phase 4 | Unknown | Fondazione Policlinico Universitario Agostino Gemelli IRCCS | 120 | 2021-07-01 | 2024-07-26 |
| Dapagliflozin on Hypotensive Heart Failure Patients After Sacubitril/Valsartan Therapy Dapagliflozin, Sacubitril-Valsartan, Beta blocker - Hypotension, Heart Failure | Phase 4 | Completed | Cheng-Hsin General Hospital | 78 | 2020-05-29 | 2021-08-02 |
| Asian Diabetes Outcomes Prevention Trial Renin-angiotensin-aldosterone system inhibitors, Beta blocker, SGLT2 Inhibitor - Sodium Glucose Cotransporter Subtype 2 Inhibitor Product - Diabetes Mellitus, Cardiovascular Diseases | Phase 4 | Recruiting | National Heart Centre Singapore | 2400 | 2019-07-01 | 2021-04-30 |
| Effect of Evolocumab on Coronary Atherosclerosis Evolocumab, 18F-NaF PET, CCTA - Cardiovascular Disease, Hyperlipidemia | Phase 3 | Completed | Cedars-Sinai Medical Center | 55 | 2019-03-19 | 2024-07-17 |
| Effect of Genetic Polymorphism on the Occurrence of Post-Operative Atrial Fibrillation After CABG Beta blocker - Coronary Bypass Graft Surgery, Atrial Fibrillation | Completed | Ain Shams University | 256 | 2019-03-11 | 2021-11-09 | |
| Randomized Evaluation of Beta Blocker and ACEI/ARB Treatment in MINOCA Patients - MINOCA-BAT Beta blocker, ACEI, ARB - Myocardial Infarction With Non-obstructive Coronary Arteries | Phase 4 | Terminated | Uppsala University | 198 | 2018-12-16 | 2023-11-27 |
| TREatment With Beta-blockers After myOcardial Infarction withOut Reduced Ejection fracTion" Beta blocker - Myocardial Infarction | Phase 4 | Completed | Fundación Centro Nacional de Investigaciones Cardiovasculares Carlos III | 8505 | 2018-10-31 | 2025-06-06 |
Showing 20 of 37. Sign in to see all of them.
Heart Failure (6) · Cardiovascular Diseases (4) · Coronary Artery Disease (3) · Diabetes Mellitus (3) · Heart Diseases (3) · Hypertension (3) · Angina Pectoris, Variant (2) · Hypotension (2) · MINOCA (2) · Myocardial Infarction (2) · Acute Coronary Syndrome (1) · Amyloid Neuropathies, Familial (1) · Angina Pectoris (1) · Aortic Valve Stenosis (1) · Atherosclerosis (1)
Cedars-Sinai Medical Center (2) · Johns Hopkins University (2) · Weill Medical College of Cornell University (2) · Abant Izzet Baysal University (1) · Ain Shams Maternity Hospital (1) · Ain Shams University (1) · Bangabandhu Sheikh Mujib Medical University, Dhaka, Bangladesh (1) · Beth Israel Deaconess Medical Center (1) · Charite University, Berlin, Germany (1) · Cheng-Hsin General Hospital (1) · Chongqing Medical University (1) · Curtin University (1) · David Lanfear (1) · Fondazione Policlinico Universitario Agostino Gemelli IRCCS (1) · Fundación Centro Nacional de Investigaciones Cardiovasculares Carlos III (1)
United States (14) · Italy (3) · Spain (3) · Australia (2) · China (2) · Egypt (2) · Bangladesh (1) · Brazil (1) · Cyprus (1) · Germany (1) · Greece (1) · Israel (1) · New Zealand (1) · Norway (1) · Singapore (1)
Parag Goyal, MD, MSc (2) · Alp Ozel, PT, PhD (1) · Bertil Lindahl, Prof (1) · Carolyn Lam Prof (1) · Daniel S. Berman, MD (1) · David Lanfear, MD (1) · Debiao Li, PhD (1) · Dina M El Gindy, MSC (1) · Dipak Kotecha (1) · Fernando Alfonso, MD (1) · Henry Krum (1) · Hung-Yu Chang, MD (1) · Jeffrey Berger, MD (1)
PMID 19152871, PMID 21953407, PMID 23327629, PMID 24727262, PMID 24906863, PMID 25193873, PMID 27098105, PMID 28408039, PMID 33203618, PMID 34474011, PMID 34969173, PMID 35066509, PMID 35734824, PMID 35943114, PMID 36107363, PMID 36526898, PMID 37587606, PMID 38458796, PMID 39743172, PMID 40178463, PMID 40888702, PMID 41811641, PMID 42034335, PMID 42246870, PMID 42478107
K76AG064428 (1), K76AG088428 (1), R01HL082638 (1), R03HL138068 (1), R21EY035483 (1), R24AG064025 (1)